_id
69171aca3c536f8df23165c8
Ticker
SXTC
Name
China SXT Pharmaceuticals Inc
Exchange
NASDAQ
Address
178 Taidong Road North, Taizhou, China, 225300
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.sxtchina.com
Description
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Last Close
1.8
Volume
493499
Current Price
0.095
Change
-0.06
Last Updated
2026-01-07T12:43:48.384Z
Image
data:image/webp;base64,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
Ipo Date
2019-01-04T00:00:00.000Z
Market Cap
196086928
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
455709
Cost Of Revenue
339372
Gross Profit
116337
Operating Expenses
1137443
Operating Income
-1021106
Interest Expense
232875
Pretax Income
-1250542
Net Income
-1250542
Eps
-0.5119544828184758
Dividends Per Share
-
Shares Outstanding
116027226
Income Tax Expense
-
EBITDA
-1014227
Operating Margin
-224.06974626351465
Total Other Income Expense Net
-229436
Cash
18099019
Short Term Investments
137804
Receivables
1900152
Inventories
828053
Total Current Assets
21296491
Property Plant Equipment
355209
Total Assets
21663508
Payables
1158298
Short Term Debt
772194
Long Term Debt
-
Total Liabilities
6223746
Equity
15439762
Bs_currency_symbol
-
Depreciation
223047
Change In Working Capital
121511
Cash From Operations
-494077
Capital Expenditures
1012
Cash From Investing
11486
Cash From Financing
580989
Net Change In Cash
-
Cf_currency_symbol
-
PE
-
PB
0.015029686986107687
ROE
-8.099490134627722
ROA
-5.772573860152289
FCF
-495089
Fcf Percent
-1.0864147954067178
Piotroski FScore
1
Health Score
34
Deep Value Investing Score
5.5
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
1
Momentum Investing Score
5.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
5.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
455709
Quarters > 0 > income Statement > cost Of Revenue
339372
Quarters > 0 > income Statement > gross Profit
116337
Quarters > 0 > income Statement > operating Expenses
1137443
Quarters > 0 > income Statement > operating Income
-1021106
Quarters > 0 > income Statement > interest Expense
232875
Quarters > 0 > income Statement > pretax Income
-1250542
Quarters > 0 > income Statement > net Income
-1250542
Quarters > 0 > income Statement > eps
-0.5119544828184758
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
2442682
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1014227
Quarters > 0 > income Statement > operating Margin
-224.06974626351465
Quarters > 0 > income Statement > total Other Income Expense Net
-229436
Quarters > 0 > income Statement > currency_symbol
-
Quarters > 0 > balance Sheet > cash
18099019
Quarters > 0 > balance Sheet > short Term Investments
137804
Quarters > 0 > balance Sheet > receivables
1900152
Quarters > 0 > balance Sheet > inventories
828053
Quarters > 0 > balance Sheet > total Current Assets
21296491
Quarters > 0 > balance Sheet > property Plant Equipment
355209
Quarters > 0 > balance Sheet > total Assets
21663508
Quarters > 0 > balance Sheet > payables
1158298
Quarters > 0 > balance Sheet > short Term Debt
772194
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
6223746
Quarters > 0 > balance Sheet > equity
15439762
Quarters > 0 > balance Sheet > currency_symbol
-
Quarters > 0 > cash Flow > net Income
-1250542
Quarters > 0 > cash Flow > depreciation
223047
Quarters > 0 > cash Flow > change In Working Capital
121511
Quarters > 0 > cash Flow > cash From Operations
-494077
Quarters > 0 > cash Flow > capital Expenditures
1012
Quarters > 0 > cash Flow > cash From Investing
11486
Quarters > 0 > cash Flow > cash From Financing
580989
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > cash Flow > currency_symbol
-
Quarters > 0 > ratios > PE
-0.5119544828184758
Quarters > 0 > ratios > PB
0.015029686986107687
Quarters > 0 > ratios > ROE
-8.099490134627722
Quarters > 0 > ratios > ROA
-5.772573860152289
Quarters > 0 > ratios > FCF
-495089
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-1.0864147954067178
Quarters > 0 > health Score
34
Quarters > 1 > quarter
2024-12-31
Quarters > 1 > income Statement > revenue
455709
Quarters > 1 > income Statement > cost Of Revenue
339372
Quarters > 1 > income Statement > gross Profit
116337
Quarters > 1 > income Statement > operating Expenses
1137443
Quarters > 1 > income Statement > operating Income
-1021106
Quarters > 1 > income Statement > interest Expense
232875
Quarters > 1 > income Statement > pretax Income
-1250542
Quarters > 1 > income Statement > net Income
-1250542
Quarters > 1 > income Statement > eps
-0.5119544828184758
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
2442682
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-1014227
Quarters > 1 > income Statement > operating Margin
-224.06974626351465
Quarters > 1 > income Statement > total Other Income Expense Net
-229436
Quarters > 1 > income Statement > currency_symbol
-
Quarters > 1 > balance Sheet > cash
18099019
Quarters > 1 > balance Sheet > short Term Investments
137804
Quarters > 1 > balance Sheet > receivables
1301335
Quarters > 1 > balance Sheet > inventories
1129103
Quarters > 1 > balance Sheet > total Current Assets
21296491
Quarters > 1 > balance Sheet > property Plant Equipment
355209
Quarters > 1 > balance Sheet > total Assets
21663508
Quarters > 1 > balance Sheet > payables
1158298
Quarters > 1 > balance Sheet > short Term Debt
772194
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
6223746
Quarters > 1 > balance Sheet > equity
15439762
Quarters > 1 > balance Sheet > currency_symbol
-
Quarters > 1 > cash Flow > net Income
-1250542
Quarters > 1 > cash Flow > depreciation
223047
Quarters > 1 > cash Flow > change In Working Capital
121511
Quarters > 1 > cash Flow > cash From Operations
-494077
Quarters > 1 > cash Flow > capital Expenditures
1012
Quarters > 1 > cash Flow > cash From Investing
11486
Quarters > 1 > cash Flow > cash From Financing
580989
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > cash Flow > currency_symbol
-
Quarters > 1 > ratios > PE
-0.5119544828184758
Quarters > 1 > ratios > PB
0.015029686986107687
Quarters > 1 > ratios > ROE
-8.099490134627722
Quarters > 1 > ratios > ROA
-5.772573860152289
Quarters > 1 > ratios > FCF
-495089
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-1.0864147954067178
Quarters > 1 > health Score
34
Quarters > 2 > quarter
2024-06-30
Quarters > 2 > income Statement > revenue
414745
Quarters > 2 > income Statement > cost Of Revenue
347368
Quarters > 2 > income Statement > gross Profit
67377
Quarters > 2 > income Statement > operating Expenses
386511
Quarters > 2 > income Statement > operating Income
-319134
Quarters > 2 > income Statement > interest Expense
91236
Quarters > 2 > income Statement > pretax Income
-401284
Quarters > 2 > income Statement > net Income
-401284
Quarters > 2 > income Statement > eps
-0.9934739552386611
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
403920
Quarters > 2 > income Statement > income Tax Expense
211462
Quarters > 2 > income Statement > EBITDA
-284864
Quarters > 2 > income Statement > operating Margin
-76.94703974731462
Quarters > 2 > income Statement > total Other Income Expense Net
-82150
Quarters > 2 > income Statement > currency_symbol
-
Quarters > 2 > balance Sheet > cash
18512756
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1663998
Quarters > 2 > balance Sheet > inventories
1588551
Quarters > 2 > balance Sheet > total Current Assets
21988312
Quarters > 2 > balance Sheet > property Plant Equipment
443210
Quarters > 2 > balance Sheet > total Assets
30997352
Quarters > 2 > balance Sheet > payables
1662730
Quarters > 2 > balance Sheet > short Term Debt
9574314
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
15962396
Quarters > 2 > balance Sheet > equity
15034956
Quarters > 2 > balance Sheet > currency_symbol
-
Quarters > 2 > cash Flow > net Income
-401284
Quarters > 2 > cash Flow > depreciation
78496
Quarters > 2 > cash Flow > change In Working Capital
-542418
Quarters > 2 > cash Flow > cash From Operations
-678590
Quarters > 2 > cash Flow > capital Expenditures
3532
Quarters > 2 > cash Flow > cash From Investing
20272
Quarters > 2 > cash Flow > cash From Financing
3618588
Quarters > 2 > cash Flow > net Change In Cash
306083
Quarters > 2 > cash Flow > currency_symbol
-
Quarters > 2 > ratios > PE
-0.9934739552386611
Quarters > 2 > ratios > PB
0.00255221232439922
Quarters > 2 > ratios > ROE
-2.6690068131892106
Quarters > 2 > ratios > ROA
-1.294575097898685
Quarters > 2 > ratios > FCF
-682122
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-1.6446780551905387
Quarters > 2 > health Score
23
Quarters > 3 > quarter
2023-12-31
Quarters > 3 > income Statement > revenue
494457
Quarters > 3 > income Statement > cost Of Revenue
361642
Quarters > 3 > income Statement > gross Profit
132815
Quarters > 3 > income Statement > operating Expenses
-3284087
Quarters > 3 > income Statement > operating Income
3416902
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
3298813
Quarters > 3 > income Statement > net Income
3298813
Quarters > 3 > income Statement > eps
3.8030082243706063
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
867422
Quarters > 3 > income Statement > income Tax Expense
211462
Quarters > 3 > income Statement > EBITDA
3678613
Quarters > 3 > income Statement > operating Margin
691.0412836707742
Quarters > 3 > income Statement > total Other Income Expense Net
-118089
Quarters > 3 > income Statement > currency_symbol
-
Quarters > 3 > balance Sheet > cash
12070345
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1314781
Quarters > 3 > balance Sheet > inventories
809757
Quarters > 3 > balance Sheet > total Current Assets
14233359
Quarters > 3 > balance Sheet > property Plant Equipment
564693
Quarters > 3 > balance Sheet > total Assets
23127057
Quarters > 3 > balance Sheet > payables
1279516
Quarters > 3 > balance Sheet > short Term Debt
3400338
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
9196611
Quarters > 3 > balance Sheet > equity
13930446
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
3298813
Quarters > 3 > cash Flow > depreciation
90281
Quarters > 3 > cash Flow > change In Working Capital
-325965
Quarters > 3 > cash Flow > cash From Operations
-674243
Quarters > 3 > cash Flow > capital Expenditures
3532
Quarters > 3 > cash Flow > cash From Investing
3392
Quarters > 3 > cash Flow > cash From Financing
918654
Quarters > 3 > cash Flow > net Change In Cash
306083
Quarters > 3 > cash Flow > currency_symbol
-
Quarters > 3 > ratios > PE
3.8030082243706063
Quarters > 3 > ratios > PB
0.005915466740978716
Quarters > 3 > ratios > ROE
23.680598596771418
Quarters > 3 > ratios > ROA
14.26386850691811
Quarters > 3 > ratios > FCF
-677775
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-1.3707460911666738
Quarters > 3 > health Score
69
Annuals > 0 > quarter
2025-03-31
Annuals > 0 > income Statement > revenue
1740907
Annuals > 0 > income Statement > cost Of Revenue
1373480
Annuals > 0 > income Statement > gross Profit
367427
Annuals > 0 > income Statement > operating Expenses
3047906
Annuals > 0 > income Statement > operating Income
-2680479
Annuals > 0 > income Statement > interest Expense
648221
Annuals > 0 > income Statement > pretax Income
-3303652
Annuals > 0 > income Statement > net Income
-3303652
Annuals > 0 > income Statement > eps
-8.178976034858389
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
403920
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-2573134
Annuals > 0 > income Statement > operating Margin
-153.97025803216368
Annuals > 0 > income Statement > total Other Income Expense Net
-623173
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
18099019
Annuals > 0 > balance Sheet > short Term Investments
137804
Annuals > 0 > balance Sheet > receivables
1900152
Annuals > 0 > balance Sheet > inventories
828053
Annuals > 0 > balance Sheet > total Current Assets
21296491
Annuals > 0 > balance Sheet > property Plant Equipment
355209
Annuals > 0 > balance Sheet > total Assets
21663508
Annuals > 0 > balance Sheet > payables
1158298
Annuals > 0 > balance Sheet > short Term Debt
772194
Annuals > 0 > balance Sheet > long Term Debt
96264
Annuals > 0 > balance Sheet > total Liabilities
6223746
Annuals > 0 > balance Sheet > equity
15439762
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-3303652
Annuals > 0 > cash Flow > depreciation
82297
Annuals > 0 > cash Flow > change In Working Capital
-971735
Annuals > 0 > cash Flow > cash From Operations
-2345333
Annuals > 0 > cash Flow > capital Expenditures
2023
Annuals > 0 > cash Flow > cash From Investing
63516
Annuals > 0 > cash Flow > cash From Financing
8399153
Annuals > 0 > cash Flow > net Change In Cash
6052245
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-8.178976034858389
Annuals > 0 > ratios > PB
0.044212132285458804
Annuals > 0 > ratios > ROE
-21.397039669393866
Annuals > 0 > ratios > ROA
-15.249847808582063
Annuals > 0 > ratios > FCF
-2347356
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-1.3483523243918256
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2024-03-31
Annuals > 1 > income Statement > revenue
1928497
Annuals > 1 > income Statement > cost Of Revenue
1374526
Annuals > 1 > income Statement > gross Profit
553971
Annuals > 1 > income Statement > operating Expenses
3069188
Annuals > 1 > income Statement > operating Income
-2515217
Annuals > 1 > income Statement > interest Expense
544279
Annuals > 1 > income Statement > pretax Income
-3098532
Annuals > 1 > income Statement > net Income
-3098532
Annuals > 1 > income Statement > eps
-3.572115994291129
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
867422
Annuals > 1 > income Statement > income Tax Expense
3
Annuals > 1 > income Statement > EBITDA
-2351010
Annuals > 1 > income Statement > operating Margin
-130.42369264769403
Annuals > 1 > income Statement > total Other Income Expense Net
-583315
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
12070345
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1346415
Annuals > 1 > balance Sheet > inventories
809757
Annuals > 1 > balance Sheet > total Current Assets
14233359
Annuals > 1 > balance Sheet > property Plant Equipment
564693
Annuals > 1 > balance Sheet > total Assets
23127057
Annuals > 1 > balance Sheet > payables
1279516
Annuals > 1 > balance Sheet > short Term Debt
2352788
Annuals > 1 > balance Sheet > long Term Debt
117129
Annuals > 1 > balance Sheet > total Liabilities
9196611
Annuals > 1 > balance Sheet > equity
13930446
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-3098532
Annuals > 1 > cash Flow > depreciation
203247
Annuals > 1 > cash Flow > change In Working Capital
-381559
Annuals > 1 > cash Flow > cash From Operations
-1928053
Annuals > 1 > cash Flow > capital Expenditures
7063
Annuals > 1 > cash Flow > cash From Investing
26423
Annuals > 1 > cash Flow > cash From Financing
-2624428
Annuals > 1 > cash Flow > net Change In Cash
-5291291
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-3.572115994291129
Annuals > 1 > ratios > PB
0.10523303991846347
Annuals > 1 > ratios > ROE
-22.242877220155048
Annuals > 1 > ratios > ROA
-13.397865539052376
Annuals > 1 > ratios > FCF
-1935116
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-1.0034322065318224
Annuals > 1 > health Score
29
Annuals > 2 > quarter
2023-03-31
Annuals > 2 > income Statement > revenue
1971679
Annuals > 2 > income Statement > cost Of Revenue
1545408
Annuals > 2 > income Statement > gross Profit
426271
Annuals > 2 > income Statement > operating Expenses
6033780
Annuals > 2 > income Statement > operating Income
-5607509
Annuals > 2 > income Statement > interest Expense
476776
Annuals > 2 > income Statement > pretax Income
-5934772
Annuals > 2 > income Statement > net Income
-5934772
Annuals > 2 > income Statement > eps
-22.229858450105443
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
266973
Annuals > 2 > income Statement > income Tax Expense
476776
Annuals > 2 > income Statement > EBITDA
-5207837
Annuals > 2 > income Statement > operating Margin
-284.4027349279472
Annuals > 2 > income Statement > total Other Income Expense Net
-327263
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
17368478
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1344569
Annuals > 2 > balance Sheet > inventories
531254
Annuals > 2 > balance Sheet > total Current Assets
19521247
Annuals > 2 > balance Sheet > property Plant Equipment
1268264
Annuals > 2 > balance Sheet > total Assets
29554056
Annuals > 2 > balance Sheet > payables
1377850
Annuals > 2 > balance Sheet > short Term Debt
3390897
Annuals > 2 > balance Sheet > long Term Debt
117862
Annuals > 2 > balance Sheet > total Liabilities
14862761
Annuals > 2 > balance Sheet > equity
14691295
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-5934772
Annuals > 2 > cash Flow > depreciation
250162
Annuals > 2 > cash Flow > change In Working Capital
1415510
Annuals > 2 > cash Flow > cash From Operations
-80757
Annuals > 2 > cash Flow > capital Expenditures
70684
Annuals > 2 > cash Flow > cash From Investing
-12303
Annuals > 2 > cash Flow > cash From Financing
2941602
Annuals > 2 > cash Flow > net Change In Cash
1798859
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-22.229858450105443
Annuals > 2 > ratios > PB
0.030711000629964885
Annuals > 2 > ratios > ROE
-40.39652052456914
Annuals > 2 > ratios > ROA
-20.081074489403417
Annuals > 2 > ratios > FCF
-151441
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-0.076808141690407
Annuals > 2 > health Score
24
Annuals > 3 > quarter
2022-03-31
Annuals > 3 > income Statement > revenue
2602281
Annuals > 3 > income Statement > cost Of Revenue
1350638
Annuals > 3 > income Statement > gross Profit
1251643
Annuals > 3 > income Statement > operating Expenses
6441316
Annuals > 3 > income Statement > operating Income
-5189673
Annuals > 3 > income Statement > interest Expense
36695
Annuals > 3 > income Statement > pretax Income
-5407949
Annuals > 3 > income Statement > net Income
-5736095
Annuals > 3 > income Statement > eps
-137.91673679401794
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
41591
Annuals > 3 > income Statement > income Tax Expense
328146
Annuals > 3 > income Statement > EBITDA
-5051246
Annuals > 3 > income Statement > operating Margin
-199.42784810710296
Annuals > 3 > income Statement > total Other Income Expense Net
-218276
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
15524322
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
5525460
Annuals > 3 > balance Sheet > inventories
1017527
Annuals > 3 > balance Sheet > total Current Assets
22451855
Annuals > 3 > balance Sheet > property Plant Equipment
1590889
Annuals > 3 > balance Sheet > total Assets
33546273
Annuals > 3 > balance Sheet > payables
1482192
Annuals > 3 > balance Sheet > short Term Debt
2046351
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
17121565
Annuals > 3 > balance Sheet > equity
16424708
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-5736095
Annuals > 3 > cash Flow > depreciation
320007
Annuals > 3 > cash Flow > change In Working Capital
1903062
Annuals > 3 > cash Flow > cash From Operations
268293
Annuals > 3 > cash Flow > capital Expenditures
62490
Annuals > 3 > cash Flow > cash From Investing
-46909
Annuals > 3 > cash Flow > cash From Financing
1595140
Annuals > 3 > cash Flow > net Change In Cash
2210644
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-137.91673679401794
Annuals > 3 > ratios > PB
0.004279454465796287
Annuals > 3 > ratios > ROE
-34.92357367936161
Annuals > 3 > ratios > ROA
-17.09905300061202
Annuals > 3 > ratios > FCF
205803
Annuals > 3 > ratios > Piotroski FScore
2
Annuals > 3 > ratios > fcf Percent
0.07908561757934673
Annuals > 3 > health Score
31
Valuation > metrics > PE
-0.5119544828184758
Valuation > metrics > PB
0.015029686986107687
Valuation > final Score
70
Valuation > verdict
98.5% Undervalued
Profitability > metrics > ROE
-8.099490134627722
Profitability > metrics > ROA
-5.872056574954062
Profitability > metrics > Net Margin
-2.7441678790631743
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.40309857107901015
Risk > metrics > Interest Coverage
-4.384781535158346
Risk > final Score
42
Risk > verdict
High
Liquidity > metrics > Current Ratio
11.031639084751452
Liquidity > metrics > Quick Ratio
10.602705424316703
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
70
Prev Valuations > 1
70
Prev Valuations > 2
90
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
100
Prev Risks > 0
42
Prev Risks > 1
16
Prev Risks > 2
84
Prev Liquidities > 0
100
Prev Liquidities > 1
99
Prev Liquidities > 2
100
Updated At
2026-01-20T22:39:41.648Z
Earnings History > 0 > period
2025-06-30
Earnings History > 0 > report Date
2025-07-31
Earnings History > 0 > date
2025-06-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-1.02
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
-1.02
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-12-31
Earnings History > 1 > report Date
2025-03-28
Earnings History > 1 > date
2024-12-31
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-1.99
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
-1.99
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2022-06-30
Earnings History > 2 > report Date
2022-07-18
Earnings History > 2 > date
2022-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-2.03
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-2.03
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2021-12-31
Earnings History > 3 > report Date
2022-01-14
Earnings History > 3 > date
2021-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.2
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
-0.2
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2021-06-30
Earnings History > 4 > report Date
2021-08-13
Earnings History > 4 > date
2021-06-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.27
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
-0.27
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2020-12-31
Earnings History > 5 > report Date
2021-01-28
Earnings History > 5 > date
2020-12-31
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.1
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
0.1
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2020-09-30
Earnings History > 6 > report Date
2020-12-31
Earnings History > 6 > date
2020-09-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.1331
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
-0.1331
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2020-06-30
Earnings History > 7 > report Date
2020-07-31
Earnings History > 7 > date
2020-06-30
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.42
Earnings History > 7 > eps Estimate
0
Earnings History > 7 > eps Difference
-0.42
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2020-03-31
Earnings History > 8 > report Date
2020-04-22
Earnings History > 8 > date
2020-03-31
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.1
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.1
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2019-12-31
Earnings History > 9 > report Date
2020-03-31
Earnings History > 9 > date
2019-12-31
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.594
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
-0.594
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2019-09-30
Earnings History > 10 > report Date
2019-12-31
Earnings History > 10 > date
2019-09-30
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.594
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
-0.594
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2019-06-30
Earnings History > 11 > report Date
2019-08-15
Earnings History > 11 > date
2019-06-30
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.07
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
0.07
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2019-03-31
Earnings History > 12 > report Date
2019-06-30
Earnings History > 12 > date
2019-03-31
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.2066
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
-0.2066
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2018-12-31
Earnings History > 13 > report Date
2019-03-28
Earnings History > 13 > date
2018-12-31
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
0.05
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
0.05
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2018-09-30
Earnings History > 14 > report Date
2018-10-03
Earnings History > 14 > date
2018-09-30
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
0.02
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
0.02
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2018-06-30
Earnings History > 15 > report Date
2018-09-30
Earnings History > 15 > date
2018-06-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
0.0995
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0.0995
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2018-03-31
Earnings History > 16 > report Date
2018-05-07
Earnings History > 16 > date
2018-03-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
0.04
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
0.04
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2017-12-31
Earnings History > 17 > report Date
2018-03-31
Earnings History > 17 > date
2017-12-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
0.036
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
0.036
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2017-06-30
Earnings History > 18 > report Date
2017-09-30
Earnings History > 18 > date
2017-06-30
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
0.078
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0.078
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2017-03-31
Earnings History > 19 > report Date
2017-06-30
Earnings History > 19 > date
2017-03-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
0.078
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
0.078
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2016-12-31
Earnings History > 20 > report Date
2017-03-31
Earnings History > 20 > date
2016-12-31
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
0.075
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.075
Earnings History > 20 > surprise Percent
-
China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company serves pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was incorporated in 2005 and is headquartered in Taizhou, China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/ATake Profit: How HTH stock responds to job market shifts - Trade Entry Report & Consistent Income Trade Ideas bollywoodhelpline.com
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
Very Low
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.08% of the total shares of China SXT Pharmaceuticals Inc
1.
UBS Group AG(0.054%)
since
2025/06/30
2.
Virtu Financial LLC(0.012%)
since
2025/06/30
3.
Fidelity® NASDAQ Composite Index®(0.0095%)
since
2023/10/31
4.
Tower Research Capital LLC(0.0001%)
since
2025/06/30
5.
Acadian Asset Management LLC(0%)
since
2025/03/31
6.
Bank of Montreal(0%)
since
2025/03/31
7.
BMO Capital Markets Corp.(0%)
since
2025/03/31
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-06-30
EPS Actual
-1.02
EPS Estimate
0
EPS Difference
-1.02
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.